Mycostatin and Protein total decreased - a phase IV clinical study of FDA data

Summary:

Protein total decreased is reported as a side effect among people who take Mycostatin (nystatin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Bactrim, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Protein total decreased when taking Mycostatin. It is created by eHealthMe based on reports of 4,130 people who have side effects when taking Mycostatin from the FDA, and is updated regularly.

What is Mycostatin?

Mycostatin has active ingredients of nystatin. eHealthMe is studying from 4,144 Mycostatin users. Check the latest studies of Mycostatin.

What is Protein total decreased?

Protein total decreased is found to be associated with 724 drugs and 929 conditions by eHealthMe. Check the latest studies of Protein total decreased.

On Jul, 06, 2026

4,130 people reported to have side effects when taking Mycostatin.
Among them, 12 people (0.29%) have Protein total decreased.

Could Mycostatin cause Protein total decreased?

Among these 12 people:

How long have people been on Mycostatin when they have Protein total decreased? *

What is the gender of people who have Protein total decreased when taking Mycostatin? *

female: 25 %
male: 75 %

What is the age of people who have Protein total decreased when taking Mycostatin? *

What are other drugs people take besides Mycostatin? *

What are other side effects people have besides Protein total decreased? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 91.67%
White Blood Cell Count Decreased: 9 people, 75.00%
Haemoglobin Decreased: 9 people, 75.00%
Blood Glucose Increased: 8 people, 66.67%
Blood Urea Increased: 7 people, 58.33%
Diarrhea: 7 people, 58.33%
Red Blood Cell Count Decreased: 6 people, 50.00%
Abdominal Pain: 6 people, 50.00%
Blood Albumin Decreased: 6 people, 50.00%
Blood Calcium Decreased: 6 people, 50.00%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 33.33%
Pain: 2 people, 16.67%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 8.33%
Oral Candidiasis (fungal infection of mouth): 1 person, 8.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mycostatin and have Protein total decreased?

- Check whether Protein total decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycostatin:

Mycostatin (4,144 reports)

Browse all side effects of Mycostatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Protein total decreased:

Protein total decreased (724 drugs)

Browse all the conditions that are associated with Protein total decreased:

Protein total decreased (929 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Mycostatin) and Mycostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.